Premium Nahrungsergänzungsmittel | artgerecht

Complex I – NADH Dehydrogenase of the Respiratory Chain

Complex I is the largest enzyme of the mitochondrial respiratory chain and plays a central role in cellular energy production via ATP synthesis.

Regular tips about health Regular tips about health

Things worth knowing about "Complex I"

Complex I is the largest enzyme of the mitochondrial respiratory chain and plays a central role in cellular energy production via ATP synthesis.

What is Complex I?

Complex I, also known as NADH:ubiquinone oxidoreductase or NADH dehydrogenase, is the first and largest enzyme complex of the mitochondrial respiratory chain (also called the electron transport chain). It is embedded in the inner mitochondrial membrane and consists of more than 45 subunits in humans. Complex I plays an essential role in ATP synthesis, the primary energy currency of the cell.

Mechanism of Action

Complex I catalyzes the transfer of two electrons from NADH (nicotinamide adenine dinucleotide, reduced form) to ubiquinone (Coenzyme Q). Simultaneously, four protons (H+) are pumped from the mitochondrial matrix into the intermembrane space. This process generates an electrochemical proton gradient across the inner mitochondrial membrane, which drives the ATP synthase (Complex V) to produce ATP – a process known as oxidative phosphorylation.

Step-by-Step Overview

NADH donates electrons to Complex I and is oxidized to NAD+.
Electrons are transferred through iron-sulfur clusters within the enzyme to ubiquinone.
Ubiquinone is reduced to ubiquinol (QH₂) and passes electrons to Complex III.
Simultaneously, protons are pumped from the matrix into the intermembrane space.
The resulting proton gradient drives ATP synthesis.

Metabolic Importance

Complex I is the primary entry point for electrons from the citric acid cycle and fatty acid oxidation into the respiratory chain. It contributes substantially to the total ATP production of the cell. Tissues with high energy demands, such as the heart muscle, skeletal muscle, brain, and liver, are particularly dependent on proper Complex I activity.

Diseases Caused by Complex I Defects

Mutations or dysfunction of Complex I are among the most common causes of mitochondrial diseases. These can result from mutations in mitochondrial DNA (mtDNA) or nuclear DNA (nDNA).

Clinical Presentations

MELAS syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes)
Leigh syndrome (subacute necrotizing encephalomyelopathy, often presenting in infancy)
Leber Hereditary Optic Neuropathy (LHON)
Progressive muscle weakness and cardiomyopathy
Developmental delays in children

Biochemical Consequences of Complex I Deficiency

Reduced ATP production and cellular energy deficit
Increased production of reactive oxygen species (ROS), causing oxidative stress
Accumulation of NADH and lactate (lactic acidosis)

Inhibition of Complex I

Various substances can inhibit Complex I, with both toxicological and pharmacological relevance:

Rotenone: A plant-derived insecticide and fish poison, considered the classic Complex I inhibitor and widely used in research. Rotenone exposure has been linked to an increased risk of Parkinson disease.
MPP+ (1-methyl-4-phenylpyridinium): The toxic metabolite of MPTP, which selectively damages dopaminergic neurons and produces a Parkinson-like syndrome.
Metformin: The widely used antidiabetic drug mildly and moderately inhibits Complex I – an effect that contributes to its blood-glucose-lowering action.
Certain pesticides and environmental toxins can impair Complex I function.

Complex I and Neurodegenerative Diseases

Reduced Complex I activity has been detected in the brains of patients with Parkinson disease and Alzheimer disease. Mitochondrial dysfunction and oxidative stress caused by Complex I defects are thought to contribute to neurodegeneration. This connection makes Complex I an important research target for neuroprotective therapies.

Diagnosis of Complex I Defects

Diagnosis is established through a combination of:

Enzyme activity measurement in muscle biopsies or fibroblasts
Genetic analysis of mitochondrial and nuclear DNA
Lactate and pyruvate measurements in blood and cerebrospinal fluid (markers of mitochondrial dysfunction)
Imaging (brain MRI when mitochondrial encephalopathy is suspected)

References

Zhu J, Vinothkumar KR, Hirst J. Structure of mammalian respiratory complex I. Nature. 2016;536(7616):354-358.
Fassone E, Rahman S. Complex I deficiency: clinical features, biochemistry and molecular genetics. Journal of Medical Genetics. 2012;49(9):578-590.
Nicholls DG, Ferguson SJ. Bioenergetics 4. Academic Press; 2013.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category